Iguratimod in treatment of primary Sjögren’s syndrome concomitant with autoimmune hemolytic anemia: A case report

BACKGROUND: Primary Sjögren's syndrome (pSS) concomitant with autoimmune hemolytic anemia (AIHA) but without eye and mouth dryness is exceedingly rare. Iguratimod (IGU) has been widely used in the treatment of pSS. However, there are few reports about the application of IGU in pSS concomitant w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Juan, Wang, Xin, Tian, Jing-Jing, Zhu, Rong, Duo, Rui-Xue, Huang, Yi-Chen, Shen, Hai-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855182/
https://www.ncbi.nlm.nih.gov/pubmed/35211561
http://dx.doi.org/10.12998/wjcc.v10.i4.1286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855182/
https://www.ncbi.nlm.nih.gov/pubmed/35211561
http://dx.doi.org/10.12998/wjcc.v10.i4.1286

Ejemplares similares